prostate radiotherapy

Sreekanth Palvai Michael Harrison Sharon Shibu Thomas Karen Hayden James Green Oliver Anderson Lavinia Romero Richard Lodge Patricia Burns Imtiaz Ahmed

BACKGROUND Prostate cancer is the most common cancer in males in the UK and affects around 105 men for every 100,000. The role of radiotherapy in the management of prostate cancer significantly changed over the last few decades with developments in brachytherapy, external beam radiotherapy (EBRT), intensity-modulated radiotherapy (IMRT), and image-guided radiotherapy (IGRT). One of the challeng...

متن کامل

Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer

2016

Hideyasu Tsumura Takefumi Satoh Hiromichi Ishiyama Ken-ichi Tabata Shouko Komori Akane Sekiguchi Masaomi Ikeda Shinji Kurosaka Tetsuo Fujita Masashi Kitano Kazushige Hayakawa Masatsugu Iwamura

PURPOSE To evaluate the prognostic value of prostate-specific antigen nadir (nPSA) after high-dose-rate (HDR) brachytherapy in clinically non-metastatic high-risk prostate cancer patients. MATERIAL AND METHODS Data from 216 patients with high-risk or locally advanced prostate cancer who underwent HDR brachytherapy and external beam radiation therapy with long-term androgen deprivation therapy...

متن کامل

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید